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Abstract
OBJECTIVE: We employed an agile, user-centered approach to the design of a clinical decision support tool in our prior
integrated clinical prediction rule study, which achieved high adoption rates. To understand if applying this user-centered
process to adapt clinical decision support tools is effective in improving the use of clinical prediction rules, we examined
utilization rates of a clinical decision support tool adapted from the original integrated clinical prediction rule study tool to
determine if applying this user-centered process to design yields enhanced utilization rates similar to the integrated clinical
prediction rule study.
MATERIALS & METHODS: We conducted pre-deployment usability testing and semi-structured group interviews at 6 months
post-deployment with 75 providers at 14 intervention clinics across the two sites to collect user feedback. Qualitative data
analysis is bifurcated into immediate and delayed stages; we reported on immediate-stage findings from real-time field
notes used to generate a set of rapid, pragmatic recommendations for iterative refinement. Monthly utilization rates were
calculated and examined over 12 months.
RESULTS: We hypothesized a well-validated, user-centered clinical decision support tool would lead to relatively high
adoption rates. Then 6 months post-deployment, integrated clinical prediction rule study tool utilization rates were substantially lower than anticipated based on the original integrated clinical prediction rule study trial (68%) at 17% (Health
System A) and 5% (Health System B). User feedback at 6 months resulted in recommendations for tool refinement, which
were incorporated when possible into tool design; however, utilization rates at 12 months post-deployment remained low at
14% and 4% respectively.
DISCUSSION: Although valuable, findings demonstrate the limitations of a user-centered approach given the complexity of
clinical decision support.
CONCLUSION: Strategies for addressing persistent external factors impacting clinical decision support adoption should be
considered in addition to the user-centered design and implementation of clinical decision support.
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Background and Significance
Clinical decision support (CDS) tools have been at
the forefront of digital health solutions for more
than 10 years.1,2 The implementation of the Health
Information Technology for Economic and Clinical
Health and Affordable Care Acts sets the stage for
widespread testing and adoption of CDS tools to promote optimal care delivery. Yet, these objectives have
been constrained by well-documented barriers to CDS
effectiveness, including poor usability, alert fatigue,
and low utilization.3–5 Together, these barriers have
impeded the impact of CDS on health outcomes, quality of care, and cost reductions.6–8

User-centered CDS
To address these barriers, CDS adoption studies have
increasingly used an agile, user-centered design (UCD)
approach with a focus on human-computer interaction
(HCI).9 In these approaches, CDS tools are created in
collaboration with users to best reflect needed content,
workflow, and ease of use.10,11 Commonly used in digital marketing and online commerce, user-centered
design principles are increasingly used by the healthcare industry to increase usability, acceptability, and
effectiveness of healthcare information technologies.12,13 In a systematic review comparing models of
adoption of CDS, the most significant factors driving
adoption was a system’s ability to be dynamic, launch
“multiple assumptions,” and incorporate “new information in response to changing circumstances,” all factors heavily dependent on an explicit understanding of
system end users.14
Figure 1 illustrates our user-centered process model
for digital design used in this and previous CDS development projects.15 The four-phase model, executed by
a team of multidisciplinary stakeholders, uses a process
of discovery paired with product definition and development phases characterized by rapid cycle agile
testing—an implementation involving wireframing,
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workflow analysis, and usability testing—to develop
and update tool design based on feedback regarding
user needs and shifting contexts.16,17 Importantly, the
model takes into consideration the CDS module
lifecycle, including the need to consider adaptations
or further “optimization” as additional user needs are
identified or changes in practice or technology, such as
electronic health record (EHR) functionality, are
encountered.
Our previous study (referred to as integrated clinical
prediction rule 1 (iCPR1)) employed this UCD framework to develop an iCPR CDS tool for reducing antibiotic prescribing for upper respiratory infections.18
The design and workflow of the tool was created
through iterative cycles of design, function, and usability testing, and content creation and revision with
stakeholders; this resulted in a CDS tool with an adoption rate five times greater than previous reports.19,20
In nearly two-thirds of opportunities, clinicians used
the offered iCPR1 tool, an antibiotic evidence-based
CDS pathway, in more than half of all iCPR1 encounters; they went on to use the associated bundled order
set (a pre-specified set of medications, tests, and documentation). This represents a substantial improvement
from earlier studies of CDS tools for acute upper respiratory infection, which demonstrated utilization rates
as low as 6%.21 The success of the original iCPR1 tool
points to the strengths of the agile, user-centered
approach to CDS tool design and highlights the value
of our tailored application of this industry practice for
academic research.22–24

Adapted iCPR study to date
Our objectives for the adapted iCPR project (iCPR2)
were to apply this approach to adapt and scale up the
implementation of the iCPR CDS tool to a diverse
group of 33 primary care clinics across multiple
institutions. To understand if applying a user-centered
process to adapt CDS tools is effective in improving the
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Figure 1. Process model for user-centered digital development.
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use of clinical prediction rules, we assessed resulting utilization rates, and ultimately, the tool’s impact on antibiotic prescription rates for acute respiratory infection in
two academic health systems. Prior publications from
this project outline the initial user-centered tool design
process including initial tool development based on feedback from assessment-focused key informant interviews
with providers, clinic managers, and medical assistants
at each site.18,19,25,26 Findings highlight an understanding of general clinic workflows, specific workflows, policies, and practices around rapid strep and chest x-ray
testing, and clinic organizational structure as related to
implementation process and tool requirements.25 Nearlive and live usability testing was conducted, and the
iCPR2 tool iteratively revised accordingly, as reported
in previous publications.18,19,26–28

Objectives
The objective of this study was to examine utilization
rates of the adapted tool (iCPR2) across sites over 12
months post-deployment to determine if applying this
user-centered process to the design of the tool yields
enhanced utilization rates similar to that in iCPR1.

Methods
Study design
As part of a large, randomized controlled trial involving over 40,000 visits in which we adapt and scale up
the implementation of the iCPR1 tool to diverse clinics
in two academic health systems, we collected qualitative user feedback during tool development, and quantitative and quantitative data on tool use over the first
12 months of implementation. Utilization data were
reviewed biweekly for 12 months post-deployment to
assess ongoing engagement with the tools by site and to
determine the need for and direction of further
user feedback, data collection, and tool iteration,
with the goal of identifying barriers and facilitators to
use as indicated by differences in utilization rates
post-deployment.

Data collection and analysis
Usability. Qualitative usability data were collected predeployment using: 1) key informant interviews with
CDS and clinical content experts and local clinical
leaders, 2) think-aloud, 3) near-live, and 4) live usability methodologies to gather information for initial tool
development and iteration; the use of these methodologies in collecting usability data for the purposes of
adaptive design is described in detail in our previous
publications and summarized below.18,19,27,28
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The initial prototype of the iCPR2 tool was
subjected to multiple rounds of usability testing in
increasingly realistic clinical simulations. During these
usability tests, providers (n¼12) were presented with
simulated cases and asked to “think-aloud” by
verbalizing thought processes as they interacted with
the prototype iCPR2 tool to examine usability aspects
of the tool.
Think-aloud sessions were followed by “near-live”
testing with the same prototype in which provider volunteers were asked to interact with a simulated patient
to collect data on how the tool fit (or did not fit) with
provider workflows. Observational “live” usability was
conducted with three providers using the tool in six real
clinical encounters to assess previously unidentified
barriers to tool use. Post-deployment usability data
were collected via semi-structured group interviews
with providers across a convenience sample of the 33
intervention clinics (n¼14) to collect qualitative user
feedback 6 months post-deployment. All providers
(physicians, nurses, nurse practitioners, and medical
assistants) who may have been exposed to the iCPR2
tool in practice at intervention sites were invited via
clinic administrators to participate in a 30–45 minute
group interview session in which they were asked questions related to usability aspects of the tool (see Table 1
for sample questions from the interview guide).
Full screen capture and audio was recorded for each
think-aloud, near-live, and live-usability session using
MoraeVR and CamtasiaVR software. Post-deployment
group interviews were recorded with detailed field
notes and then summarized. Qualitative usability data
analysis is bifurcated into immediate and delayed
stages; this paper reports immediate stage findings
aimed at generating rapid, pragmatic recommendations
for iterative refinement as they apply to design decisions and tool utilization. Participant comments were
placed into a priori (according to key usability principles) as well as inductively derived coding categories,
Table 1. Post-deployment usability feedback interview
guide excerpt.
Interview question

Usability theme

How have the results of the tool, including
the smartsets, been useful or not when
providing care to your patients?

Utility

Does the tool trigger when you expect it to?

Workflow

Is the tool easy to use?

Ease of use

How has your time with patients been
affected by use of the tool?

Burden

4
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and analyzed for generalizable themes to translate into
tool design recommendations. The delayed phase of
analysis features deeper, systematic thematic analysis
of transcribed field notes to identify generalizable
insights for CDS.
Utilization. To determine the rate and variability in utilization of the iCPR2 tool across settings, monthly utilization rates (as measured by calculator completion) at
each participating health system were calculated and
compared at 6 and 12 months post-deployment to
determine if utilization increased with tool iteration.
To accomplish this, weekly reports were generated on
the utilization of each step of the iCPR2 tool pathways
for each intervention site. These reports identified rates
of tool triggering by the relevant chief complaint and
actions taken (or not taken) by the providers (in aggregate and by clinical site).

Study sites
The study was conducted at primary care clinics associated with two large academic health systems: one
Midwestern (Health System A) and the other in the
Intermountain United States (Health System B). All
general internal medicine (GIM) and family medicine
(FM) primary care clinics at the two institutions were
invited to participate. A total of 33 individual clinics
(12 GIM clinics, 16 FM clinics, and five combined clinics) participated in the study. Each site used the same
EHR system (Epic Systems, Verona, WI) and its native
functionality (i.e., meaning no custom software development in addition to what is standardly available in
the EHR was used) to develop the iCPR tools in their
EHR. Each site was supported by an information technology department that adapted and tested the components of the iCPR tool before deployment.

Chief complaint/ diagnosis/
abx combination

Ex. abx combination:
hoarseness, fever,
laryngitis, wheezing,
dyspnea, fever,
rhinitis

The iCPR2 tool and workflow were adapted from those
developed in our original iCPR study, as outlined
above.19 In the pre-deployment phase of the current
study, the iCPR2 design was developed by an interdisciplinary team of experts in primary care, usability, and
clinical informatics at each institution (see Feldstein
et al. for details on the design process).25
The initial iteration of the new iCPR2 tool was triggered by relevant activity in any of the following EHR
fields: chief complaint, diagnosis, or diagnosis along
with antibiotic ordering. When triggered, the clinician
is presented with an alert offering the iCPR2 tool upon
opening the chart. If the alert is accepted (versus dismissed or ignored), the clinician is taken to a screen
with a list of clinical questions, each of which contributes to a total risk score (see calculator description
below with depiction in Figure 2), based on the triggering information. Temperature and heart rate are automatically populated, as applicable, based on vital signs
logged by the medical assistant. After completing the
tool, clinicians are then offered a pre-populated order
set based on the calculated risk (Figure 2).

Results
Pre-deployment results: User feedback and
subsequent adaptation of iCPR tool
The iCPR2 tool was modified based on user feedback
in the prototype phase at each site to reflect the workflow and other key clinical process differences between
the sites. For example, across Health System B, primary care providers heavily leveraged an EHR-assisted
documentation pathway in which the medical assistants
typically completed the chief complaint field and

Pneumonia Factors
(yes/no):
Temperature
Crackles
Decreased breath
sounds
Absence of asthma

Ex. diagnosis
pharyngitis, cough,
strep, URI,
bronchitis,
pneumonia

Ex. complaint:
sore throat. cough/
chest congestion/
URI symptoms

The tool: iCPR2

Alert triggers

Enters criteria in calculator
to generate risk score*

Clicks links to view
appropriate bundles order
set

Selects and signs items from
bundled order set

Step Pharyngitis
Factors (yes/no):
History of fever
Lack of cough
Tonsillar Exudates
Tender anterior
cervical notes

*Risk is calculated by documentation flowsheets to allow calculation of risk scores based on CPR criteria, using simple yes/no buttons for choosing if the criteria were met. Factors such as age, heart rate
and temperature were automatically entered in the criteria from birthdate in the EHR and the current encounter vitals.

Figure 2. Adapted integrated clinical prediction rule 1 (iCPR2) project tool and provider workflow.
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initiated a structured history of the present illness.
Results of near-live usability testing indicated an
opportunity to leverage this default workflow at
Health System B by modifying the tool so that medical
assistants gathered pieces of the history or physical
exam that were relevant to iCPR2 and prepopulated
the respective fields in the provider’s view of the tool.
As a result, from the provider perspective, the iCPR2
tool was embedded into the usual collaborative documentation workflow with an additional EHR section
with the standard view representing the partially completed iCPR2 strep or pneumonia risk calculator tool
(see Figure 3).
In contrast, the Health System A-affiliated clinical
sites do not use structured documentation and preferred a version of iCPR2 that adhered more closely
to the original provider-initiated iCPR workflow. After
a relevant chief complaint was entered, a visibly
highlighted non-interruptive alert was presented to
the provider that encouraged engagement with the
iCPR2 tool (Figure 4). Further information on design
and the usability testing during development of the
tools can be found in our three previous papers.18,25,26
Table 2 features usability design themes identified
from qualitative usability data collected in the predeployment phase of the user-centered design process
(see Methods for description of analysis approach)
matched with resulting modifications made in tool
design prior to iCPR2 tool deployment.
In response to clinician feedback related to concerns
regarding the negative effects on workflow and
increased burden of potentially irrelevant tool triggers
and alert fatigue, less-specific chief complaint triggers
of cough, upper respiratory infection, and sore throat
were chosen instead of a previously used (in iCPR)
longer list of more specific but potentially mismatched
chief complaints, ultimately prioritizing alert sensitivity
over specificity. To balance out the low specificity triggers and minimize clinician frustration and alert
fatigue, we chose to use non-interruptive alerts (not
requiring user action to resolve the alert in order to
continue with work) for the initial iCPR2 chief
complaint-based trigger.29,30 We also explored EHR
functionality that could allow for non-interruptive
alerts for the triggers based on the visit diagnosis triggers, however, no mechanisms exist within the EHR to
allow for this, so we initially opted for interruptive
alerts if iCPR was triggered by a relevant diagnosis
or diagnosis plus antibiotic prescription.

Post-deployment phase: Utilization rates and
user feedback
Figure 5 illustrates the overall rates of the iCPR2 tool
utilization at each site for both strep and pneumonia
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combined as compared with utilization rates (as measured by calculator completion rates) seen in the iCPR1
study over the first year of implementation.
By 6 months post-deployment, it had become apparent that iCPR2 tool utilization rates were substantially
lower than anticipated based on the original iCPR trial
(68%), with calculator completion rates of 17% at
Health System A and 5% at Health System B. These
results were the impetus for the additional site visits and
post-deployment provider group interviews described
below. At 12 months, after additional refinements
based on user feedback at 6 months, utilization rates
remained similarly low at 14% and 4% respectively.

Post-deployment user feedback
Post-deployment, provider-group interviews with over
75 providers in 14 intervention clinics across sites
highlighted several persistent usability issues and
other potential drivers of the relatively low utilization
rates of iCPR2 (Table 3), which were previously
unidentified in pre-deployment usability testing. These
issues/drivers include: lack of training, perceived
increased burden not identified prior to deployment
(e.g., too many “clicks,” lack of specificity due to seasonal variation), concerns related to alert fatigue,
workflow barriers to use, and lack of provider buy-in
with regard to the tool’s utility.
To address the potential for lack of timely training
for new providers as a potential driver of low utilization rates, additional academic detailing was held for
all physicians and specifically newly on-boarded physicians 6 months post-deployment. An analysis of click
counts required for use of Health System A’s calculator
and order set for each condition was performed to
explore opportunities to relieve burden by reducing
clicks (Table 4).
As indicated in Table 4, the click breakdown for
finding and completing the calculator for each condition, the number of clicks required is minimal. The
research team determined that the tool was optimal
from this perspective and further reduction in clicks
was not feasible. Post-deployment usability findings
highlighted other key usability issues and drivers less
amenable to quick iteration, yet these findings offer
interesting insights into potential limitations and persistent challenges with CDS generally.

Discussion
This study sought to adapt an innovative CDS tool
across diverse ambulatory settings using a usercentered, agile approach to design and implementation.
Our user-centered approach allowed for a rapid
yet rigorous tool-adaption plan involving substantial
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Figure 3. Health System B’s visually integrated non-interruptive alert.
! 2017 Epic Systems Corporation. Used with permission.
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Figure 4. Health System A’s highlighted non-interruptive alert.
! 2017 Epic Systems Corporation. Used with permission.
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Table 2. Pre-deployment user feedback excerpts and tool modifications per usability theme.
Usability driver/issue

User excerpt

Design decision/modification

Prepopulated data fields
leverage natural workflows/minimize workload

“I liked the fact that it actually obtains and pulls
in the clinical information that’s discrete,
that’s available, such as the heart rate and
the temperature.”

Pieces of patient history gathered by
medical assistant prepopulate in providers’ view per site natural workflow.

Interruptive alerts disruptive to natural workflow

"I much prefer to have stuff in the background
that doesn’t force me to have hard stops. . .
There may be a whole series of other things
I’m dealing with."

Created static alert able to be silenced
permanently by provider.

Lack of visibility

“But the score is way over on the right so I
didn’t actually notice what the score was.”

Alert moved to left side.

Evidence up-to-date and
specialty specific

“I don’t even know that I would give kids
cephalexin because again it tastes horrible.”

Medications in smartsets aligned with
organizational recommendations

80
70
60
50
40
30
20
10
0

1

2

3

4

Health System A

5

6

7

8

Health System B

9

10 11 12
Original iCPR

Figure 5. Utilization of integrated clinical prediction rule 1 (iCPR)
and adapted iCPR1 (iCPR2) (both conditions).

engagements with study providers in multiple settings,
from pre-deployment, think-aloud sessions to postdeployment group interviews with users. Based on
pre- and post-deployment user feedback, the iCPR2
tool was modified iteratively and site specifically and,
ultimately, most of the original iCPR CDS tool and its
underlying evidence was conserved, while accommodating new workflows in the adapted iCPR2 model.
We hypothesized that the integration of a wellvalidated, highly usable CDS tool into the EHR
would lead to relatively high adoption rates and, as a
result, reduced antibiotic prescription and diagnostic
test ordering as in the original iCPR study. However,
our findings demonstrate the complexity of CDS tools
and the likelihood that, even with the use of this stateof-the-art approach to digital health design and testing,
there can be persistent external factors impacting adoption rates that we could not address. Process measures
from the intervention arm indicated substantially lower

utilization rates than hypothesized at the study outset
despite our rigorous adaptive design process.
Adoption rates appear to demonstrate a stepped
pattern. Essentially, the lower the adoption rate, the
more divergent it is from the original iCPR tool
design. As indicated in Figure 5, the rate of completion
of the iCPR calculator at 6 months post-deployment
was 68% in the original iCPR study, but only 14% at
the Health System A and 4% in the Health System B
affiliated clinics. The stepwise adoption rates suggest
there are powerful mediating factors influencing provider utilization of the tools. The ameliorating modifications identified from post-deployment user feedback
were primarily technical and not possible in the current
EHR environment. In addition, we discovered that
adaptive design, with its focus on responsiveness to
the end user, led to a tool in the case of Health
System B that may have been “overdesigned” to the
wishes of the clinicians that the resulting iteration featured almost non-existent visual cues. Resulting cues
ended up being so passive that they were ultimately
too easy to ignore, diffusing the impact on provider
adoption. Although our study was not designed to
definitively determine which of these design issues
wielded the most influence, our findings (including
ongoing feedback from users and key stakeholders)
suggest several promising theories.
Key user feedback throughout the iCPR2 tool development and iteration cycle thus far has highlighted
alert fatigue and the potential for the tool to contribute
to already heavy demands on provider attention as
barriers to acceptance. The original iCPR trial was
conducted early after the implementation of the EHR
at that health system, a time when CDS tools were less
pervasive. At the time of the original iCPR study, just a
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Table 3. Examples of post-deployment user feedback and related adapted integrated clinical prediction rule 1 tool modifications per
usability theme.
Usability
issue/driver

User feedback examples

Modification

Lack of training

Providers that did not receive original academic detailing
never tried tool.

Additional academic detailing

Alert fatigue/
lack of
sensitivity

Lack of specificity in symptom (e.g., cough) yields lack of
specificity with regard to firing of tool.

None identified

Workflow
barriers

Triggered too early in the process, especially if patient had
multiple issues (unaware they could retrieve tool).

Methods to return to tools covered in
repeat academic detailing

Added burden

Tool is “one more thing” to do during visits.

Click counts examined, further
reductions deemed not possible

Lack of buy-in/
tool not useful

Providers familiar with criteria so stopped using/tool did not
change how care was provided. After using it providers are
comfortable with the criteria so do not need to use it.

None identified

Table 4. Adapted integrated clinical prediction rule 1 click counts
to calculator and order set per tool version, Health System A.
Sore throat adult tool

Clicks

To find calculator

1

To complete calculator

4

To find order set

2

Sore throat child tool

Clicks

To find calculator

1

To complete calculator

4

To find order set

2

Cough tool

Clicks

To find calculator

1

To complete calculator

3

To find order set

2

few CDS tools and alerts were implemented within its
EHR, and the providers had likely not yet built up
significant “alert fatigue.”31,32 Since that time, the
EHR has become inundated with alerts vying for providers’ attention. It is certainly plausible that the reduction in adoption seen in iCPR2 is in part due to the
higher level of CDS alert fatigue creating a higher
threshold of importance required for providers to

engage with a tool like iCPR2. Unfortunately, the
design changes that were recommended for decreasing
less clinically relevant triggers were not possible in the
current EHR environment; this finding points to
the urgency of identifying methods for “smarter” alerting whether through machine learning, personalization
by role, or exploring potential to build and incorporate
CDS tools outside of the EHR.
Changes in study setting related to professional level
of the pool of users (eg, resident versus attending
at sites may be an additional issue not identified in
feedback contributing to the changes in tool adoption
from iCPR1 to iCPR2. The original iCPR study was
conducted at a single urban academic hospital clinic
composed of a high percentage of trainees compared
to attending-level providers. In contrast, iCPR2 was
conducted across two large health systems that encompass over 30 distinct primary care sites composed of
mostly attending-level physicians. Results from postdeployment key user feedback are similar to other
reports documenting differences in CDS engagement
among different levels of provider training and career
phases.33 Should the professional level of the user be a
significant factor in CDS usage, the lower concentration of trainees at iCPR2 study sites could be a driver
of the lower rates of tool usage compared to the original study.
Provider professional level and level of experience
with CDS is an additional human factor to be considered in the UCD process for CDS. The drop-off in
CDS adoption among more experienced clinicians corresponds to their qualitative feedback, indicating a
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belief that evidence provided by the CDS tool became
less useful as they became more comfortable with the
decision rules. This feedback, together with the fact
that the sites in iCPR2 had a more experienced pool
of users, suggests there may be value in exploring a
more dynamic CDS system able to provide stricter
“guardrails” for engagement among inexperienced
clinicians (or at least inexperienced with this particular
CDS), but less proactive engagement as clinicians gain
experience with the tool and their practice behaviors
maintain acceptable clinical standards.33 Strategies
for delineating the specific ways in which experience
level impacts adoption of CDS tools as well as potential ways, such as the incorporation of machine learning in this context, are being explored by our team.
Final analysis of data from iCPR2 will offer further
insight into the role of experience level of provider
behavior to inform the development of the next generation of CDS tools.
Low adoption rates may also be an unintentional
impact of over-design of the tool to accommodate clinical workflow. A purposeful decision to guard against
burden, the user-centered approach may have, particularly in the case of Health System B, allowed the
workflow to overcorrect by completely sacrificing visibility for the sake of accommodating expressed provider preference for low burden, passive alerts. This fact
limited the tool’s ability to influence provider behavior
and engagement with the CDS tool. We are revising
Health System B’s workflow to more closely align
with Health System A and the original iCPR workflow
to understand if the low use reflects design or other
factors such as provider culture. This speculation
does not suggest that user-centered design is inappropriate for the adaptation of CDS tools in established
EHR workflows. Instead, it calls attention to the need
for a user-centered design approach in the context of
CDS, and potentially other healthcare-related technologies, to balance the priorities of minimizing disruption
to workflow and user burden with an understanding
that some level of workflow disruption may be required
to achieve sufficient user engagement with new tools.

Limitations
This study is limited by some key challenges. Although
we can make some alterations to workflows regarding
CDS, we cannot change the actual content of the tool
as clinical decision support’s primary role is to provide
evidence-based content to users. Additionally, the user
interface of the CDS tool is constrained by the EHR
vendor software, which limits the design changes able
to be made.
Although our research indicates users agree the tools
are clinically relevant, they may not agree there is a
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clinical need for these tools. To the degree to which
provider buy-in may be associated with level of training, results from iCPR1 and comparing overall adoption rates in iCPR1 versus iCPR2 (in which study sites
contain more experienced providers), suggest that buyin may be a driver of adoption. However, the design of
this study does not provide a way to determine the
degree to which buy-in affects adoption rates.
Similarly, we cannot adjust for changes in practice of
CDS and that providers’ experience with or attitude
toward the iCPR2 tool may be shaped by experiences
with CDS tools, including “alert fatigue.” A greater
breadth of feedback from live usability sessions may
have been possible with more than the three providers/six encounters studied; given the resourceintensive nature of this type of data collection and analysis, however, this is a reasonable sample size for live
usability studies.
Another limitation may be our choice of common
patient symptoms of cough and sore throat for triggers.
Not only are more of the triggers not applicable to the
clinical situation contributing to increased alert fatigue,
but as evaluation and treatment of these common
symptoms occurs so often during primary care medical
training and practice, more senior residents and attending physicians will have already developed a routine
of history, physical exam, and treatment methods.
Because they “know what to do,” changing clinical
behavior by adding the iCPR2 tools may be less effective. Lastly, our slow response to poor adoption rates
posed an additional limitation, born of the fact that
unlike a “start-up,” we must work within parameters
of a large healthcare organization, which requires great
preparation and evidence to implement change.

Conclusion
This study provides an example of how to leverage the
principles and techniques of UCD and HCI approaches
to tailor CDS interventions to site-specific workflows to
support utilization rates necessary to positively impact
clinical outcomes, such as reducing rates of inappropriate antibiotic prescription in the case of iCPR.
Although there are limitations to CDS as illustrated
above, the adaptability of these tools, when designed
and implemented within user-centered frameworks,
contributes to CDS tools that are more likely to fit
within site-specific workflows and, subsequently, be
used more often. We found that although the tools
implemented in iCPR2 were designed to meet the specific needs of sites’ workflows and provider preferences
as in iCPR1, utilization did not reflect the rates expected
from the implementation a similar user-centered process.
Our findings offer evidence that although necessary,
user-centered design approaches are not sufficient for
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effective CDS design; our results suggest that additional
factors, including structural ones such as the EHR environment and predominance of alert fatigue, are driving
the degree to which a CDS tool such as iCPR2 is used.
Novel questions and approaches are needed to explore
the potential and limitations of UCD approaches to positively impact CDS. Our results suggest examining
CDS adoption more broadly to ask the question: how
might we address the problem of poor EHR usability
more broadly and examine how that might affect adoption of clinical prediction rules such as iCPR2?
Additionally, given the digital demands of physicians,
exploring adaption of the iCPR2 tool for use by those
other clinical roles such as nurses may provide insight
into the factors impacting CDS adoption.
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